A hard lump under the jaw… an HPV-positive head and neck cancer… and a patient determined not to settle for “big chemo and radiation.”

In this episode of Outsmart Cancer, Dr. Dino Prato, founder of Envita Medical Centers, shares how precision oncology helped an HPV-positive patient go from debilitating side effects and weight loss to remission — without the harsh toxicity of standard protocols.

Using deep multi-omics testing (DNA, RNA, immune, and spatial biology), Dr. Prato’s team identified immune suppression and cold tumor activity, then rebuilt the immune terrain using NK and dendritic cell immunotherapy, PD-1 inhibitors, and precisely targeted low-dose chemotherapy. The result: tumor debulking, restored immune function, and a full return to quality of life — achieved through immune reactivation, not destruction.

🎯 What You’ll Learn in This Episode:

• How HPV-driven cancers respond uniquely to immune-based therapy

• Why cold tumors must be “heated up” for immunotherapy to work

• How natural killer (NK) and dendritic cell therapies target viral-induced cancers

• The role of DAMPs (damage-associated molecular patterns) in activating the immune system

• How microdosed chemo and immunotherapy can work together safely

• Why mapping (DNA, RNA, immune, and spatial biology) is key to remission

📍 Envita Medical Centers – Scottsdale, AZ
🌐 Learn more: https://www.envita.com

📞 Speak to a care coordinator: 866-830-4576

“Cold tumors can’t heal until you wake the immune system up — and teach it to fight again.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at:

https://www.scirp.org/journal/paperinformation?paperid=132493